ANGELA DEGRAAF: Open Payments
NPI 1386384931 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 50 payments from 23 companies in 2025. Trend: 2023 $666 · 2024 $1,148 · 2025 $1,323
Food & beverage: $1,228Education: $95
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $206 |
| Regeneron Healthcare Solutions, Inc. | 3 | $170 |
| Exelixis Inc. | 1 | $119 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| BeiGene USA, Inc. | 2 | $111 |
| ABBVIE INC. | 3 | $64 |
| Genentech USA, Inc. | 3 | $62 |
| Celgene Corporation | 3 | $60 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
Products named: LIBTAYO, BRUKINSA, CABOMETYX, KISQALI, Polivy, REBLOZYL, KEYTRUDA, JAKAFI.
Industry payments across FL — which companies pay providers there.
